UnknownPhase 3

Micronized Purified Flavonoid- Fraction (MPFF) in the Management of Radiation Proctitis

Austria200 participantsStarted 2020-02-26

Plain-language summary

national and multi-center trial for medical therapy of chronic radiation proctitis inducing anorectal bleedings

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * signed informed consent form * male and female patients * age ≥ 18 years * patients with diagnosis of radiation proctitis with macroscopic bleeding * end of radiotherapy ≥ 3 month = 90 days ago Exclusion Criteria: * infectious proctitis * ulcerative proctitis (inflammatory bowel disease) * persons unable to understand the informed consent * persons, who are in dependent relationship with the study investigators or Sponsor * pregnant or lactating women * participation in an interventional study

What they're measuring

Number of necessary intervention

Timeframe: Day 1- Day 360

Trial details

NCT IDNCT04335617

SponsorMedical University Innsbruck

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-26

Contact for this trial

Irmgard Kronberger, MD

+43 512 504 irmgard.kronberger@i-med.ac.at

View on ClinicalTrials.gov More Proctitis Radiation trials